phase i study of pevonedistat and ibrutinib in r/r b-nhl
Published 1 year ago • 48 plays • Length 1:28Download video MP4
Download video MP3
Similar videos
-
1:39
update on a phase i/ii study of ziftomenib in patients with r/r aml
-
1:30
phase ib/iia study of azd4573 and acalabrutinib in patients with r/r dlbcl
-
1:35
update on phase i study of plamotamab in r/r nhl
-
2:41
a phase i/ii study of afm13 in combination with cord blood-derived nk cells in patients with r/r hl
-
1:46
phase ii study of acalabrutinib plus rice in r/r dlbcl
-
1:46
phase i study of costimulatory bispecific antibody ro7227166 combined with glofitamab in r/r b-nhl
-
1:18
results of a phase i study of sonrotoclax for the treatment of r/r waldenström’s macroglobulinemia
-
13:34
hematology basics: intro to the cbc the erythrocyte portion of the cbc
-
1:21:44
cell blocks and ihc in cytopathology
-
4:28
how to interpret mixing studies (prolonged pt/ptt)
-
1:38
phase ii study of epcoritamab in r/r lbcl
-
1:36
the use of tafasitamab and lenalidomide in r/r dlbcl
-
1:08
overview of the phase i study with acalabrutinib (acp-196) in cll
-
1:04
phase i/ii study of bosutinib in newly diagnosed & resistant/intolerant pediatric patients with cml
-
1:55
update on the phase i/ii bruin study
-
1:40
results from a phase i/ii study of golcadomide in r/r follicular lymphoma
-
2:04
phase i/ii study of a novel bet inhibitor, bms-986158, alone & with ruxolitinib or fedratinib in mf
-
3:56
results of the phase ii titan study of caplacizumab in patients with attp
-
2:38
car-t therapy for aggressive b-cell lymphomas
-
1:24
mm-6 study: in-class transition to a regimen of ixazomib, lenalidomide, & dexamethasone for myeloma
-
3:53
standard-of-care setting results of axi-cel in r/r large b-cell lymphoma